Gemcitabine Hydrochloride (hameln rds gmbh)
Welcome to the PulseAid listing for the Gemcitabine Hydrochloride drug offered from hameln rds gmbh. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | hameln rds gmbh |
| NON-PROPRIETARY NAME: | gemcitabine hydrochloride |
| SUBSTANCE NAME: | GEMCITABINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-09-20 |
| END MARKETING DATE: | 0000-00-00 |
Gemcitabine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Gemcitabine Hydrochloride from hameln rds gmbh |
| LABELER NAME: | hameln rds gmbh |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/5mL) |
| START MARKETING DATE: | 2012-09-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42236-001_e411d839-b51f-4e99-b0e1-2f8ace7bd53a |
| PRODUCT NDC: | 42236-001 |
| APPLICATION NUMBER: | ANDA090663 |
Other GEMCITABINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
